You can track coronavirus cases, deaths and testing rates at the national and State levels here. Given these two independent experimental studies, Niclosamide has now emerged as a promising drug candidate for clinical trial in COVID-19 patients. - PTIChinaChina authorises CoronaVac COVID-19 vaccine for children above 3 yrsChina has authorised the emergency use of CoronaVac, a COVID-19 vaccine manufactured by Chinese firm Sinovac, for children aged between 3 and 17 years, Sinovac Chairman Yin Weidong said. Today, private hospitals say the response from this age group is largely positive. Of these, 18.9 lakh are between 18 and 44 years who have got the first dose and 2,785 in the age group have got the second dose.

Source: The Hindu June 06, 2021 04:31 UTC